Absence of overexpression of KIR3DL2 on CD4+ T cells and NK cells in patients with axial spondyloarthritis

Rheumatology (Oxford). 2023 Apr 3;62(4):e114-e116. doi: 10.1093/rheumatology/keac546.

Authors

Guillaume Larid^{1

2

3}, Sophie Trijau¹, Clothilde Barral¹, Pierre Lafforgue¹, Thao Pham¹

Affiliations

¹ Rheumatology Department, Aix Marseille Univ, APHM, CHU Sainte-Marguerite, Marseille, France.
² Rheumatology Department, CHU Poitiers, Poitiers, France.
³ LITEC Laboratory, UR 15560, University of Poitiers, Poitiers, France.

PMID: 36124947
DOI: 10.1093/rheumatology/keac546

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Axial Spondyloarthritis*
CD4-Positive T-Lymphocytes
Humans
Killer Cells, Natural
Receptors, KIR3DL2
Spondylarthritis*

Substances

Receptors, KIR3DL2
KIR3DL2 protein, human